- Home
- HYFM vs EDSA Comparison
HYFM vs EDSA Comparison
Compare HYFM & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- EDSA
- Stock Information
- Founded
- HYFM 1977
- EDSA 2015
- Country
- HYFM United States
- EDSA Canada
- Employees
- HYFM N/A
- EDSA N/A
- Industry
- HYFM Industrial Machinery/Components
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- EDSA Health Care
- Exchange
- HYFM Nasdaq
- EDSA Nasdaq
- Market Cap
- HYFM 16.0M
- EDSA 13.8M
- IPO Year
- HYFM 2020
- EDSA N/A
- Fundamental
- Price
- HYFM $3.57
- EDSA $2.05
- Analyst Decision
- HYFM Hold
- EDSA Strong Buy
- Analyst Count
- HYFM 2
- EDSA 2
- Target Price
- HYFM $7.00
- EDSA $13.00
- AVG Volume (30 Days)
- HYFM 10.6K
- EDSA 33.4K
- Earning Date
- HYFM 08-07-2025
- EDSA 08-08-2025
- Dividend Yield
- HYFM N/A
- EDSA N/A
- EPS Growth
- HYFM N/A
- EDSA N/A
- EPS
- HYFM N/A
- EDSA N/A
- Revenue
- HYFM $176,650,000.00
- EDSA N/A
- Revenue This Year
- HYFM $5.45
- EDSA N/A
- Revenue Next Year
- HYFM $5.33
- EDSA N/A
- P/E Ratio
- HYFM N/A
- EDSA N/A
- Revenue Growth
- HYFM N/A
- EDSA N/A
- 52 Week Low
- HYFM $1.50
- EDSA $1.55
- 52 Week High
- HYFM $8.55
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- HYFM 50.79
- EDSA 52.89
- Support Level
- HYFM $3.50
- EDSA $1.91
- Resistance Level
- HYFM $3.83
- EDSA $2.14
- Average True Range (ATR)
- HYFM 0.36
- EDSA 0.12
- MACD
- HYFM -0.01
- EDSA 0.02
- Stochastic Oscillator
- HYFM 36.28
- EDSA 64.52
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.